Search results

An '''anti-diarrheal drug''' (or '''anti-diarrhoeal drug''' in British English) is any [[medication]] which provides symptomatic rel * [[Opioid]]s' classical use besides pain relief is as an anti-diarrhoeal drug. Opioids have [[agonist]] actions on the intestinal opioid receptors, which ...

An '''anti-diarrheal drug''' (or '''anti-diarrhoeal drug''' in British English) is any [[medication]] which provides symptomatic rel * [[Opioid]]s' classical use besides pain relief is as an anti-diarrhoeal drug. Opioids have [[agonist]] actions on the intestinal opioid receptors, which ...

{{Major Drug Groups/ja}} ...

...uld possibly equal or exceed that of [[bariatric surgery]]. The first such drug to receive approval is [[tirzepatide]], a dual agonist of GLP-1 and [[GIP r ...and the production of [[ketones]]. Unlike currently approved [[weight loss drug]]s, glucagon receptor agonists increase [[energy expenditure]]. Combination ...

...uld possibly equal or exceed that of [[bariatric surgery]]. The first such drug to receive approval is [[tirzepatide]], a dual agonist of GLP-1 and [[GIP r ...and the production of [[ketones]]. Unlike currently approved [[weight loss drug]]s, glucagon receptor agonists increase [[energy expenditure]]. Combination ...

{{Short description|Category of drugs used to classify a drug according to certain criteria}} A '''drug class''' is a set of [[medication]]s and other compounds that have a simila ...

| group3 = [[Nonsteroidal anti-inflammatory drug/ja|NSAID]] ...

{{Short description|Category of drugs used to classify a drug according to certain criteria}} A '''drug class''' is a set of [[medication]]s and other compounds that have a simila ...

{{Main/ja|Anti-obesity medication/ja}} * フェンテルミンとトピックの[[combination drug/ja|配合薬]]である。[[phentermine/topiramate/ja|フェンテルミン/トピラマート]]（Qsymia）は、慢性的な[[wei ...

...rzepatide/ja|ティルゼパチド]]の各薬剤は、カロリーを抑えた食事と身体活動の増加との併用による体重管理薬として、米国[[Food and Drug Administration/ja|食品医薬品局]]（FDA）により承認されている。2022年現在、[[bariatric surgery/ja|肥満 ...高熱症]]を引き起こし、DNP はまたいくつかのユーザーで[[cataracts/ja|白内障]]を引き起こした。1938年に[[:en:Food, Drug, and Cosmetic Act|食品、薬物、化粧品法]]の成立後、FDAは人間の消費のためのDNPを禁止した。 ...

薬物クラス（'''drug class'''）とは、類似した[[chemical structure/ja|化学構造]]を持ち、同じ[[mechanism of action/j 薬物クラスは通常、[[prototype drug/ja|プロトタイプ薬物]]によって定義され、最も重要で、通常はそのクラス内で最初に開発された薬物であり、比較の基準として使用される。 ...

...s. Any chemical substance with [[biological activity]] may be considered a drug. This list categorises drugs alphabetically and also by other categorisatio ...ti-inflammatory drug#Classification|List of nonsteroidal anti-inflammatory drug]] ...

{{Drug List/ja|state6=uncollapsed}} ...たりすることがあるが、これは直接的な影響というよりも、グルコースの急激な低下によって間接的に引き起こされると考えられている。患者の中には[[anti-drug antibodies/ja|抗薬物抗体]]を発症する者がいるが、これは他のGLP-1作動薬よりも[[exenatide/ja|エキセナチド]]でよくみ ...

'''Anti-obesity medication''' or '''weight loss medications''' are [[pharmacological]] agen ...]], [[semaglutide]], and [[tirzepatide]] are approved by the US [[Food and Drug Administration]] (FDA) for weight management in combination with reduced-ca ...

{{Drug List/ja|state6=uncollapsed}} ...f patients) than other GLP-1 agonists and can decrease the efficacy of the drug. GLP-1 agonists increase the risk of [[gallstones]] when used to induce rap ...